1 Market Overview of Next Generation Cancer Diagnostics 1.1 Next Generation Cancer Diagnostics Market Overview 1.1.1 Next Generation Cancer Diagnostics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Next Generation Cancer Diagnostics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Next Generation Cancer Diagnostics Market Size by Region (2015-2026) 1.4 Global Next Generation Cancer Diagnostics Historic Market Size by Region (2015-2020) 1.5 Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 1.6.1 North America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 1.6.2 Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) 2 Next Generation Cancer Diagnostics Market Overview by Type 2.1 Global Next Generation Cancer Diagnostics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2015-2020) 2.3 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2021-2026) 2.4 Next Generation Sequencing 2.5 qPCR & Multiplexing 2.6 DNA Microarrays 2.7 Other 3 Next Generation Cancer Diagnostics Market Overview by Application 3.1 Global Next Generation Cancer Diagnostics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2015-2020) 3.3 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2021-2026) 3.4 Hospitals 3.5 Clinics 3.6 Other 4 Global Next Generation Cancer Diagnostics Competition Analysis by Players 4.1 Global Next Generation Cancer Diagnostics Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2019) 4.3 Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market 4.4 Global Top Players Next Generation Cancer Diagnostics Headquarters and Area Served 4.5 Key Players Next Generation Cancer Diagnostics Product Solution and Service 4.6 Competitive Status 4.6.1 Next Generation Cancer Diagnostics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Cepheid 5.1.1 Cepheid Profile 5.1.2 Cepheid Main Business 5.1.3 Cepheid Products, Services and Solutions 5.1.4 Cepheid Revenue (US$ Million) & (2015-2020) 5.1.5 Cepheid Recent Developments 5.2 Koninklijke Philips N.V 5.2.1 Koninklijke Philips N.V Profile 5.2.2 Koninklijke Philips N.V Main Business and Company’s Total Revenue 5.2.3 Koninklijke Philips N.V Products, Services and Solutions 5.2.4 Koninklijke Philips N.V Revenue (US$ Million) (2015-2020) 5.2.5 Koninklijke Philips N.V Recent Development and Reaction to Covid-19 5.3 F. Hoffmann-La Roche Ltd 5.5.1 F. Hoffmann-La Roche Ltd Profile 5.3.2 F. Hoffmann-La Roche Ltd Main Business 5.3.3 F. Hoffmann-La Roche Ltd Products, Services and Solutions 5.3.4 F. Hoffmann-La Roche Ltd Revenue (US$ Million) & (2015-2020) 5.3.5 Qiagen Recent Developments 5.4 Qiagen 5.4.1 Qiagen Profile 5.4.2 Qiagen Main Business 5.4.3 Qiagen Products, Services and Solutions 5.4.4 Qiagen Revenue (US$ Million) & (2015-2020) 5.4.5 Qiagen Recent Developments 5.5 Novartis AG 5.5.1 Novartis AG Profile 5.5.2 Novartis AG Main Business 5.5.3 Novartis AG Products, Services and Solutions 5.5.4 Novartis AG Revenue (US$ Million) & (2015-2020) 5.5.5 Novartis AG Recent Developments 5.6 Abbott 5.6.1 Abbott Profile 5.6.2 Abbott Main Business 5.6.3 Abbott Products, Services and Solutions 5.6.4 Abbott Revenue (US$ Million) & (2015-2020) 5.6.5 Abbott Recent Developments 5.7 Thermo Fisher Scientific 5.7.1 Thermo Fisher Scientific Profile 5.7.2 Thermo Fisher Scientific Main Business and Company’s Total Revenue 5.7.3 Thermo Fisher Scientific Products, Services and Solutions 5.7.4 Thermo Fisher Scientific Revenue (US$ Million) (2015-2020) 5.7.5 Thermo Fisher Scientific Recent Development and Reaction to Covid-19 5.8 Opko Health 5.8.1 Opko Health Profile 5.8.2 Opko Health Main Business 5.8.3 Opko Health Products, Services and Solutions 5.8.4 Opko Health Revenue (US$ Million) & (2015-2020) 5.8.5 Opko Health Recent Developments 5.9 Myriad Genetics 5.9.1 Myriad Genetics Profile 5.9.2 Myriad Genetics Main Business 5.9.3 Myriad Genetics Products, Services and Solutions 5.9.4 Myriad Genetics Revenue (US$ Million) & (2015-2020) 5.9.5 Myriad Genetics Recent Developments 5.10 Agilent Technologies 5.10.1 Agilent Technologies Profile 5.10.2 Agilent Technologies Main Business 5.10.3 Agilent Technologies Products, Services and Solutions 5.10.4 Agilent Technologies Revenue (US$ Million) & (2015-2020) 5.10.5 Agilent Technologies Recent Developments 5.11 GE Healthcare 5.11.1 GE Healthcare Profile 5.11.2 GE Healthcare Main Business 5.11.3 GE Healthcare Products, Services and Solutions 5.11.4 GE Healthcare Revenue (US$ Million) & (2015-2020) 5.11.5 GE Healthcare Recent Developments 5.12 PerkinElmer 5.12.1 PerkinElmer Profile 5.12.2 PerkinElmer Main Business 5.12.3 PerkinElmer Products, Services and Solutions 5.12.4 PerkinElmer Revenue (US$ Million) & (2015-2020) 5.12.5 PerkinElmer Recent Developments 5.13 Genomic Health 5.13.1 Genomic Health Profile 5.13.2 Genomic Health Main Business 5.13.3 Genomic Health Products, Services and Solutions 5.13.4 Genomic Health Revenue (US$ Million) & (2015-2020) 5.13.5 Genomic Health Recent Developments 5.14 Illumina 5.14.1 Illumina Profile 5.14.2 Illumina Main Business 5.14.3 Illumina Products, Services and Solutions 5.14.4 Illumina Revenue (US$ Million) & (2015-2020) 5.14.5 Illumina Recent Developments 5.15 Hologic 5.15.1 Hologic Profile 5.15.2 Hologic Main Business 5.15.3 Hologic Products, Services and Solutions 5.15.4 Hologic Revenue (US$ Million) & (2015-2020) 5.15.5 Hologic Recent Developments 5.16 Almac Group 5.16.1 Almac Group Profile 5.16.2 Almac Group Main Business and Company’s Total Revenue 5.16.3 Almac Group Products, Services and Solutions 5.16.4 Almac Group Revenue (US$ Million) (2015-2020) 5.16.5 Almac Group Recent Development and Reaction to Covid-19 5.17 Janssen Global Services 5.17.1 Janssen Global Services Profile 5.17.2 Janssen Global Services Main Business 5.17.3 Janssen Global Services Products, Services and Solutions 5.17.4 Janssen Global Services Revenue (US$ Million) & (2015-2020) 5.17.5 Janssen Global Services Recent Developments 5.18 Sysmex Corporation 5.18.1 Sysmex Corporation Profile 5.18.2 Sysmex Corporation Main Business 5.18.3 Sysmex Corporation Products, Services and Solutions 5.18.4 Sysmex Corporation Revenue (US$ Million) & (2015-2020) 5.18.5 Sysmex Corporation Recent Developments 6 North America 6.1 North America Next Generation Cancer Diagnostics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Next Generation Cancer Diagnostics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Next Generation Cancer Diagnostics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Next Generation Cancer Diagnostics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Next Generation Cancer Diagnostics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Next Generation Cancer Diagnostics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Next Generation Cancer Diagnostics Market Size Share by Region (2015-2020) Table 4. Global Next Generation Cancer Diagnostics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Next Generation Cancer Diagnostics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Next Generation Cancer Diagnostics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Next Generation Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2015-2020) Table 9. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2021-2026) Table 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Next Generation Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2015-2020) Table 14. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2021-2026) Table 16. Global Next Generation Cancer Diagnostics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2019) Table 19. Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market Table 20. Global Next Generation Cancer Diagnostics Top Players Headquarters and Area Served Table 21. Next Generation Cancer Diagnostics Product Solution and Service Table 22. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Cepheid Basic Information List Table 25. Cepheid Description and Business Overview Table 26. Cepheid Next Generation Cancer Diagnostics Products, Services and Solutions Table 27. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Cepheid (2015-2020) Table 28. Cepheid Recent Developments Table 29. Koninklijke Philips N.V Basic Information List Table 30. Koninklijke Philips N.V Description and Business Overview Table 31. Koninklijke Philips N.V Next Generation Cancer Diagnostics Products, Services and Solutions Table 32. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Koninklijke Philips N.V (2015-2020) Table 33. Koninklijke Philips N.V Recent Developments Table 34. F. Hoffmann-La Roche Ltd Basic Information List Table 35. F. Hoffmann-La Roche Ltd Description and Business Overview Table 36. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Products, Services and Solutions Table 37. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of F. Hoffmann-La Roche Ltd (2015-2020) Table 38. F. Hoffmann-La Roche Ltd Recent Developments Table 39. Qiagen Basic Information List Table 40. Qiagen Description and Business Overview Table 41. Qiagen Next Generation Cancer Diagnostics Products, Services and Solutions Table 42. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Qiagen (2015-2020) Table 43. Qiagen Recent Developments Table 44. Novartis AG Basic Information List Table 45. Novartis AG Description and Business Overview Table 46. Novartis AG Next Generation Cancer Diagnostics Products, Services and Solutions Table 47. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Novartis AG (2015-2020) Table 48. Novartis AG Recent Developments Table 49. Abbott Basic Information List Table 50. Abbott Description and Business Overview Table 51. Abbott Next Generation Cancer Diagnostics Products, Services and Solutions Table 52. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Abbott (2015-2020) Table 53. Abbott Recent Developments Table 54. Thermo Fisher Scientific Basic Information List Table 55. Thermo Fisher Scientific Description and Business Overview Table 56. Thermo Fisher Scientific Next Generation Cancer Diagnostics Products, Services and Solutions Table 57. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Thermo Fisher Scientific (2015-2020) Table 58. Thermo Fisher Scientific Recent Developments Table 59. Opko Health Basic Information List Table 60. Opko Health Description and Business Overview Table 61. Opko Health Next Generation Cancer Diagnostics Products, Services and Solutions Table 62. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Opko Health (2015-2020) Table 63. Opko Health Recent Developments Table 64. Myriad Genetics Basic Information List Table 65. Myriad Genetics Description and Business Overview Table 66. Myriad Genetics Next Generation Cancer Diagnostics Products, Services and Solutions Table 67. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Myriad Genetics (2015-2020) Table 68. Myriad Genetics Recent Developments Table 69. Agilent Technologies Basic Information List Table 70. Agilent Technologies Description and Business Overview Table 71. Agilent Technologies Next Generation Cancer Diagnostics Products, Services and Solutions Table 72. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Agilent Technologies (2015-2020) Table 73. Agilent Technologies Recent Developments Table 74. GE Healthcare Basic Information List Table 75. GE Healthcare Description and Business Overview Table 76. GE Healthcare Next Generation Cancer Diagnostics Products, Services and Solutions Table 77. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of GE Healthcare (2015-2020) Table 78. GE Healthcare Recent Developments Table 79. PerkinElmer Basic Information List Table 80. PerkinElmer Description and Business Overview Table 81. PerkinElmer Next Generation Cancer Diagnostics Products, Services and Solutions Table 82. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of PerkinElmer (2015-2020) Table 83. PerkinElmer Recent Developments Table 84. Genomic Health Basic Information List Table 85. Genomic Health Description and Business Overview Table 86. Genomic Health Next Generation Cancer Diagnostics Products, Services and Solutions Table 87. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Genomic Health (2015-2020) Table 88. Genomic Health Recent Developments Table 89. Illumina Basic Information List Table 90. Illumina Description and Business Overview Table 91. Illumina Next Generation Cancer Diagnostics Products, Services and Solutions Table 92. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Illumina (2015-2020) Table 93. Illumina Recent Developments Table 94. Hologic Basic Information List Table 95. Hologic Description and Business Overview Table 96. Hologic Next Generation Cancer Diagnostics Products, Services and Solutions Table 97. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Hologic (2015-2020) Table 98. Hologic Recent Developments Table 99. Almac Group Basic Information List Table 100. Almac Group Description and Business Overview Table 101. Almac Group Next Generation Cancer Diagnostics Products, Services and Solutions Table 102. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Almac Group (2015-2020) Table 103. Almac Group Recent Developments Table 104. Janssen Global Services Basic Information List Table 105. Janssen Global Services Description and Business Overview Table 106. Janssen Global Services Next Generation Cancer Diagnostics Products, Services and Solutions Table 107. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Janssen Global Services (2015-2020) Table 108. Janssen Global Services Recent Developments Table 109. Sysmex Corporation Basic Information List Table 110. Sysmex Corporation Description and Business Overview Table 111. Sysmex Corporation Next Generation Cancer Diagnostics Products, Services and Solutions Table 112. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Sysmex Corporation (2015-2020) Table 113. Sysmex Corporation Recent Developments Table 114. North America Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million) Table 115. North America Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) Table 116. Europe Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million) Table 117. Europe Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) Table 118. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million) Table 119. Asia-Pacific Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) (US$ Million) Table 120. Latin America Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million) Table 121. Latin America Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) (US$ Million) Table 122. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Players (2015-2020) (US$ Million) Table 123. Middle East & Africa Next Generation Cancer Diagnostics Market Size Share by Players (2015-2020) (US$ Million) Table 124. Next Generation Cancer Diagnostics Market Trends Table 125. Next Generation Cancer Diagnostics Market Drivers Table 126. Next Generation Cancer Diagnostics Market Challenges Table 127. Next Generation Cancer Diagnostics Market Restriants Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Next Generation Cancer Diagnostics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Next Generation Cancer Diagnostics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Next Generation Cancer Diagnostics Market Share by Regions: 2020 VS 2026 Figure 4. North America Next Generation Cancer Diagnostics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Next Generation Cancer Diagnostics Market Share by Type in 2020 & 2026 Figure 10. Next Generation Sequencing Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. qPCR & Multiplexing Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. DNA Microarrays Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Next Generation Cancer Diagnostics Market Size Share by Application in 2020 & 2026 Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Clinics Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players Next Generation Cancer Diagnostics Market Share in 2019 Figure 20. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation

Cepheid Koninklijke Philips N.V F. Hoffmann-La Roche Ltd Qiagen Novartis AG Abbott Thermo Fisher Scientific Opko Health Myriad Genetics Agilent Technologies GE Healthcare PerkinElmer Genomic Health Illumina Hologic Almac Group Janssen Global Services Sysmex Corporation